David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MSDA
2151
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
| $4.2M | 0.01% |
424,547
+18,030
| +4% | +$178K |
|
2152
Qualys
QLYS
$6.28B
| $4.18M | 0.01% |
30,013
+25,613
| +582% | +$3.61M |
|
2153
Arcosa
ACA
$7.14B
| $4.18M | 0.01% |
73,134
+39,739
| +119% | +$2.2M |
|
2154
PUT
Analog Devices
ADI
$182B
| $4.18M | 0.01% |
+30,000
| New | +$4.74M |
|
2155
Voyager Therapeutics
VYGR
$213M
| $4.17M | 0.01% |
704,776
-22,366
| -3% | -$143K |
|
|
RETA
2156
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.17M | 0.01% |
165,830
-93,825
| -36% | -$2.6M |
|
|
STRE
2157
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $4.17M | 0.01% |
420,694
+62,500
| +17% | +$615K |
|
2158
KE Holdings
BEKE
$19.7B
| $4.16M | 0.01% |
237,431
+86,663
| +57% | +$1.4M |
|
2159
Curtiss-Wright
CW
$23B
| $4.16M | 0.01% |
29,886
-14,770
| -33% | -$2.1M |
|
2160
Lithia Motors
LAD
$8.1B
| $4.16M | 0.01% |
19,376
-7,363
| -28% | -$1.92M |
|
|
SWTX
2161
DELISTED
SpringWorks Therapeutics
SWTX
| $4.15M | 0.01% |
145,610
-99,853
| -41% | -$2.86M |
|
2162
TG Therapeutics
TGTX
$8.35B
| $4.15M | 0.01% |
701,000
-512,778
| -42% | -$3.36M |
|
2163
Copa Holdings
CPA
$5.95B
| $4.15M | 0.01% |
61,901
+11,174
| +22% | +$778K |
|
2164
CALL
International Paper
IP
$21.4B
| $4.15M | 0.01% |
130,800
+88,700
| +211% | +$3.63M |
|
|
GDNR
2165
DELISTED
Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
| $4.13M | ﹤0.01% |
413,469
| – | – |
|
|
SNV
2166
DELISTED
Synovus
SNV
| $4.13M | ﹤0.01% |
110,057
+66,013
| +150% | +$2.62M |
|
2167
CALL
Regal Rexnord
RRX
$11B
| $4.13M | ﹤0.01% |
+29,400
| New | +$3.95M |
|
2168
Charter Communications
CHTR
$18.1B
| $4.11M | ﹤0.01% |
13,563
+4,449
| +49% | +$1.9M |
|
|
TEN
2169
Tsakos Energy Navigation Ltd
TEN
$1.24B
| $4.11M | ﹤0.01% |
269,409
+161,382
| +149% | +$2.25M |
|
2170
CALL
Crocs
CROX
$5.87B
| $4.11M | ﹤0.01% |
59,900
+33,700
| +129% | +$2.34M |
|
2171
TPG
TPG
$8.8B
| $4.11M | ﹤0.01% |
147,604
+122,077
| +478% | +$3.53M |
|
|
VGR
2172
DELISTED
Vector Group Ltd.
VGR
| $4.11M | ﹤0.01% |
466,043
-170,573
| -27% | -$1.73M |
|
|
SGEN
2173
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.11M | ﹤0.01% |
+30,000
| New | +$4.89M |
|
|
KIII
2174
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $4.1M | ﹤0.01% |
414,066
| – | – |
|
2175
CALL
Nasdaq
NDAQ
$55.8B
| $4.1M | ﹤0.01% |
72,300
| – | – |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.